Updated: 22/04/2002

Rift Valley fever

 Aetiology  Epidemiology  Diagnosis  Prevention and control  References 

AETIOLOGY

Classification of the causative agent

Virus family Bunyaviridae, genus Phlebovirus

Resistance to physical and chemical action

Temperature: Survives several months at 4°C. In serum, inactivated by 56°C for 120 minutes
pH: Resistant to alkaline pH but inactivated by pH <6.8
Chemicals: Inactivated by ether and chloroform
Disinfectants: Inactivated by strong solutions of sodium or calcium hypochlorite (residual chlorine should exceed 5000 ppm)
Survival: Survives in dried discharges and multiplies in some arthropod vectors. Can survive contact with 0.5% phenol at 4°C for 6 months


EPIDEMIOLOGY

Hosts

Transmission

Sources of virus

Occurrence

RVF has been recognised exclusively in African countries, with an underlying association with high rainfall and dense populations of vector mosquitoes. The only epizootic outbreaks of RVF outside sub-Saharan Africa were recorded in animals and humans in Egypt in 1977-78, Mauritania in 1987 and again in Egypt in 1993. Laboratory infections have been recorded in other parts of the world

For detailed information on occurrence, see recent issues of World Animal Health and the OIE Bulletin


DIAGNOSIS

Incubation period varies from 1 to 6 days

Clinical diagnosis

Cattle

Sheep, goats and pigs

Inapparent infections are quite frequent in other species than sheep

Humans

Complications: retinopathy, blindness, meningo-encephalitis, haemorrhagic syndrome with jaundice, petechiae and death

Lesions

Differential diagnosis

Laboratory diagnosis

Procedures

Identification of the agent

Serological tests

Samples


PREVENTION AND CONTROL

No specific treatment. Symptomatic treatment in severe human cases

Sanitary prophylaxis

Hygiene and vector control have had little effect

Medical prophylaxis


REFERENCES AND OTHER INFORMATION

---------------------------------------------

[top]

Contact : scientific.dept@oie.int